![An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study) - ScienceDirect An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253818305866-fx1.jpg)
An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study) - ScienceDirect
![Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up - Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/5ad9108d-0703-42fd-a06d-d95bccd4a3ec/gr1.jpg)
Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up -
![CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram](https://www.researchgate.net/profile/Stina-Wichert/publication/313332310/figure/fig1/AS:458060259958784@1486221484711/CONSORT-flowchart-for-A-single-arm-open-label-phase-2-clinical-trial-with-BI-505-a.png)
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram
PLOS ONE: Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials
![PDF] Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | Semantic Scholar PDF] Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bebf64d9eed1781065a2c153404d554135ca30a3/3-Table1-1.png)
PDF] Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | Semantic Scholar
PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
![Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)](https://bmjopen.bmj.com/content/bmjopen/5/12/e009562/F1.large.jpg)
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)
![Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial - Clinical Nutrition Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial - Clinical Nutrition](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/225f8e6d-9bb3-4a9f-b513-2675b3a97597/gr1_lrg.jpg)
Green tea (Camellia sinensis) for patients with knee osteoarthritis: A randomized open-label active-controlled clinical trial - Clinical Nutrition
![Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram](https://www.researchgate.net/profile/Melissa-Maguire-4/publication/229531788/figure/fig1/AS:280360760954899@1443854622269/Schematic-view-of-an-open-label-extension-to-a-randomized-controlled-clinical-trial.png)
Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram
![Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study | Trials | Full Text Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-020-04991-y/MediaObjects/13063_2020_4991_Figa_HTML.png)
Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study | Trials | Full Text
![Oral Azithromycin vs Doxycycline in MGD: A Randomized Double-masked Open-label Clinical Trial | TFOS blog Oral Azithromycin vs Doxycycline in MGD: A Randomized Double-masked Open-label Clinical Trial | TFOS blog](http://www.thedryeyereview.com/wp-content/uploads/2015/01/bigstock-picture-of-doctor-hands-giving-46645024-300x223.jpg)
Oral Azithromycin vs Doxycycline in MGD: A Randomized Double-masked Open-label Clinical Trial | TFOS blog
![PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60afa7902fddea770036d6744ee84027545bd238/3-Figure1-1.png)
PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar
![Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial | Scientific Reports Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-60644-9/MediaObjects/41598_2020_60644_Fig1_HTML.png)
Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial | Scientific Reports
![Potential impact of differential drop-in of open-label diabetes medications in EXSCEL - Virtual Meeting | EASD Potential impact of differential drop-in of open-label diabetes medications in EXSCEL - Virtual Meeting | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/885_726415/Slide1.jpg)
Potential impact of differential drop-in of open-label diabetes medications in EXSCEL - Virtual Meeting | EASD
![Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK546770/bin/clapp7f1.jpg)
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
![Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/43cc48d1-0be0-403a-9246-02a545426442/gr1.gif)
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
![Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial - The Lancet Respiratory Medicine Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0ed07044-02d7-4c0e-95a7-b9a3d949e5df/gr1.jpg)